What is Eton Bioscience?
Founded in 2003 and headquartered in San Diego, California, Eton Bioscience has carved out a significant market position by offering a comprehensive suite of custom biological services and proprietary product lines. The firm serves as a critical infrastructure partner for researchers, facilitating complex experiments through specialized laboratory services. By maintaining a focus on quality and reliability, Eton Bioscience has established itself as a trusted vendor within the competitive life sciences landscape, effectively bridging the gap between raw experimental requirements and actionable scientific data.
How much funding has Eton Bioscience raised?
Eton Bioscience has raised a total of $749K across 1 funding round:
Debt
$749K
Debt (2021): $749K with participation from PPP
Key Investors in Eton Bioscience
PPP
Public-Private Partnership
What's next for Eton Bioscience?
With this major enterprise-level funding, Eton Bioscience is positioned to accelerate its growth trajectory and enhance its service delivery infrastructure. The strategic allocation of this capital will likely focus on scaling laboratory capacity, expanding its product portfolio, and integrating advanced automation to meet the evolving demands of the global research community. As the company navigates its next phase of development, the focus remains on maintaining its reputation for technical excellence while exploring new avenues for market penetration in the rapidly advancing biotech sector.
See full Eton Bioscience company page
